High level expression of a functional human/mouse chimeric anti-CD20 monoclonal antibody in milk of transgenic mice

Transgenic Research
Bo TangNing Li

Abstract

Rituximab, a chimeric anti-CD20 monoclonal antibody, is one of the most successful biomedicines and has been used to treat at least 370,000 patients with indolent, aggressive non-Hodgkin's lymphoma and other malignant diseases. However, the global demand for rituximab and other therapeutic monoclonal antibodies is exponentially increasing and barely able to be met by current manufacturing capacities of mammalian cell culture. The mammary gland bioreactor has been regarded as an ideal substitute for mammalian cell culture to mass-produce recombinant monoclonal antibodies at the lowest possible cost. Here, we show a feasible model to produce recombinant anti-CD20 antibodies in the mammary glands of transgenic animals. Six lines of transgenic mice were generated by co-microinjection of the two expression cassettes that can specially express the chimeric light and heavy chain of anti-CD20 mAbs in the milk of transgenic animals. The recombinant antibodies were detected in the milk of transgenic mice with the highest expression level up to 17 microg/mul and could specifically bind the CD20 surface antigens on human B-lymphoma cells.

References

Aug 1, 1995·Immunotechnology : an International Journal of Immunological Engineering·J LimontaJ de la Fuente
Apr 29, 1998·Journal of Virology·I SolaL Enjuanes
Dec 3, 1998·Research in Immunology·M W YoungM Harvey
Jan 29, 2000·Journal of Immunological Methods·D P PollockH M Meade
Sep 5, 2002·International Journal of Health Services : Planning, Administration, Evaluation·Eeva Ollila, Meri Koivusalo
Dec 17, 2002·Current Opinion in Biotechnology·Louis Marie Houdebine
Mar 22, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J BoyeA Engert
May 22, 2004·Nature Reviews. Drug Discovery·Janice Reichert, Alex Pavolu
Mar 23, 2005·Critical Reviews in Oncology/hematology·M Stern, R Herrmann
Jun 18, 2005·Arthritis Research & Therapy·Ann Mohrbacher
Sep 10, 2005·Nature Biotechnology·Janice M ReichertMatthew C Dewitz
Sep 10, 2005·Nature Biotechnology·Gregory P Adams, Louis M Weiner
Apr 14, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M D Pescovitz
Aug 11, 2006·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Suzanne S Farid

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.